Engineered transfer RNAs for suppression of premature termination codons
Premature termination codon suppression therapy could be used to treat a range of genetic disorders. Here the authors present a high-throughput cell-based assay to identify anticodon engineered tRNAs with high suppression activity.
Guardado en:
Autores principales: | John D. Lueck, Jae Seok Yoon, Alfredo Perales-Puchalt, Adam L. Mackey, Daniel T. Infield, Mark A. Behlke, Marshall R. Pope, David B. Weiner, William R. Skach, Paul B. McCray, Christopher A. Ahern |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/407180d474f9434ca10313d5ef3ae933 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ATP hydrolysis by UPF1 is required for efficient translation termination at premature stop codons
por: Lucas D. Serdar, et al.
Publicado: (2016) -
The effect of gentamicin-induced readthrough on a novel premature termination codon of CD18 leukocyte adhesion deficiency patients.
por: Amos J Simon, et al.
Publicado: (2010) -
Analysis of codon usage bias reveals optimal codons in Elaeis guineensis
por: Redi Aditama, et al.
Publicado: (2020) -
Translation of non-standard codon nucleotides reveals minimal requirements for codon-anticodon interactions
por: Thomas Philipp Hoernes, et al.
Publicado: (2018) -
CFTR trafficking mutations disrupt cotranslational protein folding by targeting biosynthetic intermediates
por: Hideki Shishido, et al.
Publicado: (2020)